{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T17:15:20Z","timestamp":1697908520987},"reference-count":9,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":8698,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Scandinavian Journal of Haematology"],"published-print":{"date-parts":[[1985,7]]},"abstract":"<jats:p>222 patients aged 15\u201359 years with acute leukaemia were treated with intermittent combination chemotherapy consisting of six 5\u2010day courses of cytotoxic drugs as induction treatment followed by 3 years of maintenance therapy in patients who obtained complete remission (CR). CR was achieved in 50.3% of 161 patients (early deaths included) with acute myelogenous leukaemia (AML). The observed cumulative 5\u2010yr survival rate (observation time 1\u201312.25 yr) calculated by the life table method was 12% in AML. Among patients who obtained CR, those aged 40\u201359 yr appeared to fare better than younger patients (5\u2010yr survival: 24%). The M\u20103 subtype was an adverse prognostic factor. In acute lymphoblastic leukaemia (ALL) the CR rate was 83.6% and the observed cumulative 5\u2010yr survival rate was 14%. Women fared better than men.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1985.tb00799.x","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T22:41:57Z","timestamp":1280961717000},"page":"51-55","source":"Crossref","is-referenced-by-count":4,"title":["Survival in 222 adult patients with acute leukaemia treated with intermittent combination chemotherapy programme"],"prefix":"10.1111","volume":"35","author":[{"given":"S.A.","family":"Evensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Stavem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19800415)45:8<2017::AID-CNCR2820450806>3.0.CO;2-C"},{"key":"e_1_2_1_3_2","first-page":"172","article-title":"The treatment of acute my\u2010elogenous leukemia in adults","volume":"19","author":"Lister TA","year":"1982","journal-title":"Semin Hematol"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1976.tb03563.x"},{"key":"e_1_2_1_5_2","first-page":"265","article-title":"Improvement in remission induction therapy of acute myelocytic leukemia","volume":"16","author":"Rai KR","year":"1975","journal-title":"ASCO Abstracts"},{"key":"e_1_2_1_6_2","unstructured":"ReesJKH HayhoeFGJ.Remission induction therapy in acute myeloid leukaemia.Abstracts IV Int Soc Haematol European and African Div Fifth Meeting Hamburg1979."},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1977.1"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood.V60.3.677.677","article-title":"Adolescent and adult acute lymphoblastic leukemia: prognostic features and outcome of therapy. A study of 293 patients","volume":"60","author":"Baccarani M.","year":"1982","journal-title":"Blood"},{"key":"e_1_2_1_9_2","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1182\/blood.V58.6.1203.1203","article-title":"Treatment of acute myelocytic leukaemia: a study by Cancer and Leukemia Group B","volume":"58","author":"Rai KR","year":"1981","journal-title":"Blood"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1984.tb03967.x"}],"container-title":["Scandinavian Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1985.tb00799.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1985.tb00799.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T18:56:47Z","timestamp":1697828207000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1985.tb00799.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,7]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1985,7]]}},"alternative-id":["10.1111\/j.1600-0609.1985.tb00799.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1985.tb00799.x","archive":["Portico"],"relation":{},"ISSN":["0036-553X"],"issn-type":[{"value":"0036-553X","type":"print"}],"subject":[],"published":{"date-parts":[[1985,7]]}}}